Catalyst Wire Dossier Catalyst Wire Dossier

PA-824 (pretomanid)

pretomanid
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PA-824 (pretomanid), covering 2014-11-14 to 2014-11-14. Get the full timeline:

Most recent: Clinical Trial Update: Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers [Phase 1]

See pricing